Clinical Trial Update: A Study to Compare PK, Immunogenicity and Safety of Trastuzumab of Incepta Pharmaceuticals Ltd With Trastuzumab (Roche) [Phase 1]

View source ↗

Summary

Phase 1 study comparing pharmacokinetics, immunogenicity, and safety of a trastuzumab biosimilar from Incepta Pharmaceuticals Ltd versus Roche’s trastuzumab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Trastuzumab (Incepta Pharmaceuticals Ltd) (trastuzumab)
• Trastuzumab (Roche) (trastuzumab)

Snippet

Sponsor: Incepta Pharmaceuticals Ltd | Conditions: Breast Cancer, Breast Neoplasms | Phase 1 | Status: COMPLETED